FDA NDC Directory · JSON-LD · Markdown

Fondaparinux Sodium

NDC 55111-679 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerDr. Reddy's Laboratories Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA091316
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsFONDAPARINUX SODIUM (5 mg/.4mL)
Marketing started20110714
Package count2

External sources

Source: openFDA. Public-domain (CC0).